Mercy Hospital

Mercy Hospital was paid $35.53M by Medicaid between Jan 2018 and Dec 2024, across 435 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 30% of everything it billed.

33Billing provider infoMERCY HOSPITAL
PORTLAND, ME 04102

33aNPI1629078712assigned 07/29/2005

33bProvider typeGeneral Acute Care Hospital

28Total paid$35.53M

24GClaims1,214,578

24DCodes billed435

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Maine

Rank by total paid#7 of 33

Median peer was paid$4.34M

This provider vs. median8.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	155,828	$3.61M
2019	174,057	$5.06M
2020	177,363	$4.31M
2021	204,744	$5.84M
2022	183,295	$5.50M
2023	167,896	$5.36M
2024incomplete	151,395	$5.84M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	30%	160,465	126,412	$10.48M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	11%	31,134	28,116	$3.82M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	7.9%	10,778	9,458	$2.80M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	6.4%	26,786	24,074	$2.26M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	4.9%	63,157	57,167	$1.75M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	4.4%	44,893	40,005	$1.56M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	2.3%	8,374	7,223	$803K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.2%	34,050	11,974	$766K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.6%	2,298	2,129	$578K
45380	Colonoscopy, flexible; with biopsy, single or multiple	1.6%	1,088	1,028	$556K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.3%	5,241	3,676	$474K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	1.2%	12,707	11,704	$419K

423 more codes

U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	1.1%	7,751	$409K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	1.1%	22,157	$397K
74177	Computed tomography, abdomen and pelvis; with contrast material	1.1%	2,934	$392K
71046	Radiologic examination, chest; 2 views	<1%	8,701	$318K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	4,567	$315K
90834	Psychotherapy session, about 45 minutes	<1%	3,223	$313K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	2,301	$294K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	3,299	$294K
90837	Psychotherapy session, about an hour	<1%	2,914	$253K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	622	$248K
96375	Therapeutic injection; each additional sequential IV push	<1%	6,796	$212K
70450	Computed tomography, head or brain; without contrast material	<1%	3,228	$210K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	4,205	$201K
97161		<1%	5,467	$188K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	3,379	$174K
90832	Psychotherapy session, about 30 minutes	<1%	3,158	$173K
96361	Intravenous infusion, hydration; each additional hour	<1%	5,168	$166K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	1,592	$159K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,224	$154K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,686	$153K
76830	Ultrasound, transvaginal	<1%	1,728	$123K
93976		<1%	1,798	$123K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	879	$122K
G0008	Administration of influenza virus vaccine	<1%	6,082	$112K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	2,061	$109K
90791	Psychiatric diagnostic evaluation	<1%	1,684	$106K
86900		<1%	2,895	$97K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	1,778	$97K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	7,290	$93K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	11,051	$82K
76819	Fetal biophysical profile; without non-stress testing	<1%	970	$82K
99232	Hospital visit by a doctor, follow-up day	<1%	3,528	$81K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,326	$81K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	5,633	$79K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,209	$75K
80061	Lipid panel	<1%	10,184	$72K
77063	Screening digital breast tomosynthesis, bilateral	<1%	3,344	$71K
0002A		<1%	2,518	$70K
0001A		<1%	2,695	$69K
84443	Thyroid stimulating hormone (TSH)	<1%	12,400	$66K
29581		<1%	1,319	$66K
80053	Comprehensive metabolic panel	<1%	37,409	$65K
97597		<1%	1,332	$62K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	16,171	$62K
90686		<1%	7,747	$59K
97113		<1%	1,817	$59K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	220	$57K
93971		<1%	1,159	$56K
99215	Doctor's office visit, returning patient (complex)	<1%	1,039	$55K
99309	Subsequent nursing facility care, per day, low to moderate complexity	<1%	2,369	$47K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	4,587	$44K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	4,555	$44K
99308	Subsequent nursing facility care, per day, straightforward	<1%	2,392	$39K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	4,111	$38K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	35,344	$38K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	2,315	$37K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	66	$36K
97165		<1%	1,728	$33K
41899	Unlisted procedure, dentoalveolar structures	<1%	143	$33K
76801		<1%	390	$32K
Q3014	Telehealth originating site facility fee	<1%	3,329	$31K
76642		<1%	909	$30K
36415	Collection of venous blood by venipuncture	<1%	44,355	$29K
90792	Psychiatric diagnostic evaluation with medical services	<1%	416	$28K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	1,105	$27K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	4,412	$25K
90677		<1%	746	$24K
72100		<1%	1,641	$24K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	2,107	$24K
96161		<1%	1,204	$23K
96367		<1%	547	$23K
99203	Doctor's office visit, new patient (routine)	<1%	517	$23K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	334	$23K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	313	$22K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	2,549	$21K
96127		<1%	5,847	$21K
20610		<1%	242	$21K
83036	Hemoglobin; glycosylated (A1C)	<1%	10,421	$21K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	1,098	$20K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	298	$20K
73562		<1%	2,361	$20K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	558	$19K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	168	$19K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	14,198	$19K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	765	$19K
71045	Radiologic examination, chest; single view	<1%	604	$19K
85027		<1%	9,095	$17K
97162		<1%	732	$17K
87081		<1%	8,647	$17K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	137	$17K
82728		<1%	3,136	$16K
97035		<1%	3,297	$16K
80305		<1%	17,352	$16K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	1,013	$16K
90732		<1%	250	$15K
72110		<1%	1,037	$15K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	1,863	$14K
73630		<1%	2,131	$14K
90651		<1%	413	$14K
90473		<1%	356	$14K
99204	Doctor's office visit, new patient (more involved)	<1%	261	$13K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	1,953	$12K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	13	$12K
99442		<1%	391	$12K
73610		<1%	1,631	$12K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	408	$12K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	6,572	$11K
87086	Culture, bacterial; quantitative colony count, urine	<1%	8,766	$11K
92557		<1%	251	$11K
73030		<1%	1,380	$11K
80048	Basic metabolic panel (calcium, ionized)	<1%	7,618	$11K
91322		<1%	163	$11K
64721		<1%	16	$11K
59025	Fetal non-stress test	<1%	82	$10K
12001		<1%	210	$10K
64493		<1%	27	$10K
82607		<1%	1,958	$9K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	45	$9K
90480		<1%	569	$9K
76775		<1%	279	$8K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	104	$8K
90678		<1%	28	$8K
73502		<1%	1,134	$8K
0004A		<1%	692	$8K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	110	$8K
86592		<1%	2,181	$8K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	27	$7K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	374	$7K
0124A		<1%	576	$7K
71250		<1%	170	$7K
97535	Self-care/home management training, each 15 minutes	<1%	1,886	$7K
84439		<1%	2,209	$7K
83550		<1%	2,149	$7K
77066	Tomosynthesis, mammo	<1%	118	$7K
73130		<1%	978	$6K
97166		<1%	353	$6K
84702		<1%	868	$6K
83655		<1%	1,449	$6K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,041	$6K
72050		<1%	359	$6K
87077		<1%	5,972	$6K
90670		<1%	1,995	$6K
73110		<1%	908	$6K
97116		<1%	1,361	$5K
83540		<1%	2,267	$5K
85610		<1%	6,043	$5K
82950		<1%	1,182	$5K
71275	Computed tomographic angiography, chest, with contrast material	<1%	58	$5K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	25	$5K
83735		<1%	9,114	$5K
0054A		<1%	331	$5K
10060		<1%	37	$5K
77080		<1%	146	$5K
90656		<1%	556	$5K
73140		<1%	341	$5K
64615		<1%	64	$4K
62323		<1%	31	$4K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,711	$4K
86703		<1%	2,034	$4K
87205		<1%	5,247	$4K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	14	$4K
71271		<1%	83	$4K
96160		<1%	170	$4K
86803		<1%	1,668	$4K
99223	Prolong inpt eval add15 m	<1%	55	$4K
82746		<1%	725	$4K
87186		<1%	3,245	$4K
C1776	Joint device (implantable)	<1%	410	$4K
99024		<1%	287	$4K
72125	Computed tomography, cervical spine; without contrast material	<1%	365	$4K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	16	$4K
86618		<1%	899	$3K
99381		<1%	46	$3K
90662		<1%	657	$3K
86140		<1%	3,682	$3K
81025		<1%	7,420	$3K
93017		<1%	99	$3K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	224	$3K
G0009	Administration of pneumococcal vaccine	<1%	277	$3K
91320		<1%	284	$3K
0072A		<1%	139	$3K
87340		<1%	1,953	$3K
0071A		<1%	135	$3K
G0433	Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening	<1%	315	$3K
87631		<1%	609	$3K
84153		<1%	353	$3K
97018		<1%	1,051	$3K
76536		<1%	49	$3K
74018		<1%	172	$3K
82570		<1%	5,105	$3K
82043		<1%	2,289	$2K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	38	$2K
69209		<1%	498	$2K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	151	$2K
85651		<1%	2,766	$2K
83880		<1%	1,514	$2K
0031A		<1%	94	$2K
31575		<1%	15	$2K
80076		<1%	657	$2K
83690		<1%	6,305	$2K
58300		<1%	52	$2K
87070		<1%	1,510	$2K
72141		<1%	12	$2K
87522	Neg quan hep c or qual rna	<1%	111	$2K
99205	Prolong outpt/office vis	<1%	26	$2K
99490	Ccm add 20min	<1%	44	$2K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	52	$2K
93970		<1%	14	$2K
81003		<1%	8,246	$2K
82105		<1%	134	$1K
86762		<1%	1,213	$1K
A9270	Non-covered item or service	<1%	8,166	$1K
99188		<1%	104	$1K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	168	$1K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,770	$1K
99307		<1%	96	$1K
90734		<1%	213	$1K
84403		<1%	105	$1K
G0378	Hospital observation service, per hour	<1%	1,145	$968.76
81002		<1%	3,651	$940.28
0064A		<1%	65	$930.46
71101		<1%	145	$808.27
92567		<1%	593	$786.45
97014		<1%	67	$782.11
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	25	$754.32
99406		<1%	46	$700.80
81000		<1%	3,311	$682.14
99222	Initial hospital care, per day, moderate complexity	<1%	14	$676.88
D1120	Dental cleaning, child	<1%	13	$655.80
86706		<1%	197	$655.69
72070		<1%	25	$653.75
92504		<1%	298	$649.00
87280		<1%	475	$648.19
99310	Prolong nursin fac eval 15m	<1%	22	$641.49
90461		<1%	29	$639.36
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	54	$638.40
82962		<1%	7,984	$633.21
77065	Tomosynthesis, mammo	<1%	14	$592.81
81001		<1%	4,190	$552.14
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	1,290	$549.37
82784		<1%	193	$529.68
72040		<1%	129	$523.79
83001		<1%	50	$500.87
90716		<1%	325	$490.02
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	42	$486.82
90715		<1%	3,261	$470.73
87641		<1%	72	$445.49
85018		<1%	1,140	$439.19
74022		<1%	89	$429.95
99496		<1%	15	$428.80
96381		<1%	32	$424.96
87484		<1%	81	$424.68
86850		<1%	2,960	$423.62
0012A		<1%	25	$423.24
83986		<1%	2,135	$422.92
87469		<1%	81	$421.68
87468		<1%	81	$421.68
88342		<1%	509	$414.65
87430		<1%	373	$399.26
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	1,203	$396.73
84484		<1%	4,749	$383.33
83516		<1%	92	$381.20
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	16	$350.00
84100		<1%	182	$328.37
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	28	$326.25
84315		<1%	2,124	$307.34
82550		<1%	279	$305.25
88307		<1%	77	$275.81
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	2,744	$272.00
J0690	Injection, cefazolin sodium, 500 mg	<1%	5,411	$252.00
86364		<1%	69	$244.41
87478		<1%	42	$243.60
81015		<1%	299	$221.26
72170		<1%	70	$199.82
87640		<1%	69	$191.45
J1170	Injection, hydromorphone, up to 4 mg	<1%	4,125	$183.19
J7050	Infusion, normal saline solution, 250 cc	<1%	2,728	$181.36
0134A		<1%	40	$169.50
87075		<1%	510	$165.92
84703		<1%	328	$164.74
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	14	$159.66
86038		<1%	49	$159.23
76376		<1%	739	$157.03
85730		<1%	269	$152.21
99238	Hospital discharge day management, 30 minutes or less	<1%	13	$147.98
97164		<1%	14	$147.48
86787		<1%	90	$146.84
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	27	$130.80
J2704	Injection, propofol, 10 mg	<1%	10,523	$113.79
L3908	Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf	<1%	13	$112.90
69210		<1%	12	$103.70
G2012	Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion	<1%	53	$102.26
36591		<1%	23	$102.09
85379		<1%	758	$100.92
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	12	$99.28
83993		<1%	12	$98.15
84146		<1%	13	$96.90
87449		<1%	53	$96.46
87040		<1%	445	$84.72
0111A		<1%	13	$74.40
82075		<1%	586	$73.92
73560		<1%	35	$72.63
87807		<1%	16	$70.26
83605		<1%	894	$62.30
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	562	$60.33
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	7,240	$56.63
J7030	Infusion, normal saline solution , 1000 cc	<1%	5,269	$55.13
J2060	Injection, lorazepam, 2 mg	<1%	2,219	$52.49
73080		<1%	12	$50.28
87324		<1%	39	$49.66
Q9969	Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose	<1%	206	$48.84
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	8,686	$47.13
87427		<1%	14	$46.84
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	524	$45.86
86901		<1%	2,905	$42.60
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	5,769	$39.81
87045		<1%	14	$37.76
87046		<1%	14	$37.76
83721		<1%	15	$37.48
80178		<1%	14	$32.70
82150		<1%	12	$32.60
80164		<1%	14	$29.86
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	34	$26.62
87400		<1%	136	$26.46
90744		<1%	299	$26.14
86430		<1%	12	$23.20
84460		<1%	13	$21.14
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	2,466	$20.55
82565		<1%	25	$19.96
J3370	Injection, vancomycin hcl, 500 mg	<1%	999	$19.08
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	48	$14.19
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	1,472	$13.12
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	8,103	$12.59
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	7,279	$12.54
87339		<1%	491	$11.71
86308		<1%	14	$10.58
82948		<1%	552	$8.70
A6209	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	<1%	697	$8.19
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	11,496	$6.93
82272		<1%	12	$6.90
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	1,237	$5.30
J7120	Ringers lactate infusion, up to 1000 cc	<1%	7,416	$5.14
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,127	$4.24
82077		<1%	1,341	$3.52
J2270	Injection, morphine sulfate, up to 10 mg	<1%	915	$3.14
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	6,358	$1.71
83615		<1%	22	$1.14
C9113	Injection, pantoprazole sodium, per vial	0%	306	$0.00
90633		0%	1,215	$0.00
A9575	Injection, gadoterate meglumine, 0.1 ml	0%	714	$0.00
A6210	Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing	0%	615	$0.00
A6212	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	0%	291	$0.00
76942		0%	541	$0.00
90707		0%	418	$0.00
90472	Immunization administration, each additional vaccine (list separately)	0%	5,747	$0.00
J1050	Injection, medroxyprogesterone acetate, 1 mg	0%	1,205	$0.00
91300		0%	6,112	$0.00
90710		0%	103	$0.00
J0670	Injection, mepivacaine hydrochloride, per 10 ml	0%	41	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	45	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	118	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	473	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	121	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	581	$0.00
90700		0%	331	$0.00
A6250	Skin sealants, protectants, moisturizers, ointments, any type, any size	0%	318	$0.00
91311		0%	109	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	102	$0.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	95	$0.00
80143		0%	29	$0.00
91321		0%	42	$0.00
91312		0%	321	$0.00
J3475	Injection, magnesium sulfate, per 500 mg	0%	193	$0.00
64447		0%	109	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	24	$0.00
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	0%	35	$0.00
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	0%	821	$0.00
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	0%	15	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	38	$0.00
80179		0%	14	$0.00
99152		0%	29	$0.00
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	0%	1,785	$0.00
90697		0%	744	$0.00
96376		0%	1,963	$0.00
J1630	Injection, haloperidol, up to 5 mg	0%	1,452	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	487	$0.00
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	0%	273	$0.00
J0696	Injection, ceftriaxone sodium, per 250 mg	0%	1,467	$0.00
90680		0%	1,657	$0.00
J1790	Injection, droperidol, up to 5 mg	0%	207	$0.00
J3490	Unclassified drugs	0%	1,596	$0.00
91305		0%	300	$0.00
C1769	Guide wire	0%	391	$0.00
90619		0%	36	$0.00
90698		0%	700	$0.00
A6197	Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing	0%	539	$0.00
36416		0%	563	$0.00
90474		0%	1,215	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	322	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	536	$0.00
C9290	Injection, bupivacaine liposome, 1 mg	0%	14	$0.00
94760		0%	77	$0.00
90696		0%	40	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	54	$0.00
90647		0%	238	$0.00
J2765	Injection, metoclopramide hcl, up to 10 mg	0%	27	$0.00
1123F		0%	137	$0.00
91301		0%	1,742	$0.00
88341		0%	15	$0.00
88304		0%	15	$0.00
64494		0%	25	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	33	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	76	$0.00
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	13	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	18	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	47	$0.00
90381		0%	31	$0.00
J2469	Injection, palonosetron hcl, 25 mcg	0%	20	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	329	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	26	$0.00
64415		0%	25	$0.00
91307		0%	54	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHUCK, THERESA (DELEGATED OFFICIAL)